Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.


Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019

From Critical Care Explorations

The authors piloted a randomized trial of IV immunoglobulin in coronavirus disease 2019 patients and found significantly improved hypoxia and reduced hospital length of stay.

Authors:

Sakoulas G, Geriak M, Kullar R, et al. 


Estimated Time: 23:01

Categories: Research, Disaster,
Content Type: Articles,